Research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Trading Down 0.4 %
Shares of NYSE:MLSS opened at $0.90 on Wednesday. Milestone Scientific has a 12-month low of $0.54 and a 12-month high of $1.39. The stock’s 50-day moving average price is $1.00 and its 200-day moving average price is $0.96. The stock has a market capitalization of $70.18 million, a P/E ratio of -12.87 and a beta of 1.12.
Institutional Trading of Milestone Scientific
A number of institutional investors have recently made changes to their positions in the stock. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific in the third quarter worth $48,000. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the third quarter valued at about $91,000. Renaissance Technologies LLC raised its stake in shares of Milestone Scientific by 72.8% during the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after acquiring an additional 53,198 shares during the last quarter. Carnegie Investment Counsel boosted its holdings in shares of Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Compound Interest and Why It Matters When Investing
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Stock Sentiment Analysis: How it Works
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
